Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

NanoVibronix (Nasdaq:NAOV) announced today that it intends to effect a reverse stock split of its common stock.

Short interest in NanoVibronix Inc (NASDAQ:NAOV) decreased during the last reporting period, falling from 1.66M to 95.67K. This put 1.1% of the company's publicly available shares short.

NanoVibronix (NAOV) announced that an independent health service study of its UroShield is published in The Australian and New Zealand ...

NanoVibronix Inc. (NAOV), a medical device company with a market capitalization of $1.73 million, saw its stock price touch a 52-week low of $0.44, reflecting a challenging period for the firm.

ELMSFORD, N.Y., March 14, 2025--NanoVibronix, Inc. (NASDAQ: NAOV) (the "Company"), a medical technology company specializing in non-invasive therapeutic devices, today announced that an ...

Brian Murphy, CEO of NanoVibronix, Inc., commented, "This study underscores the benefits of UroShield in enhancing patient care by reducing CAUTI incidence and catheter blockages, minimizing ...

Extends Relationship with Ultra Pain Products, Inc for Distribution of PainShield for Five Years NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the ...

Development advancing to verification and testing phase; Aims to future-proof design, lower componentry costs and improve manufacturing NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a ...

TYLER, Texas--(BUSINESS WIRE)-- NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive ...

NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced that it intends to ...